The foot and mouth disease vaccines market is projected to grow from USD 2.9 billion in 2025 to USD 6.1 billion by 2035, at a CAGR of 7.7%. Conventional vaccines will dominate with a 76.0% market share, while cattle will lead the animal type segment with a 58.0% share in 2025.